A phase I and biological correlates study of capecitabine (CAP) plus oxaliplatin (OX) plus radiation therapy (RT) in locally advanced rectal cancer (LARC).

被引：0
|
作者：
Fakih, MG [1 ]
Rajput, A [1 ]
Yang, GY [1 ]
Pendyala, L [1 ]
Toth, K [1 ]
Lawrence, DD [1 ]
Smith, JL [1 ]
Soehnlein, NA [1 ]
Flaherty, L [1 ]
Rustum, YM [1 ]
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：279S / 279S
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant bevacizumab (BEV) combined with capecitabine (C) and standard radiation therpay (RT) in locally advanced rectal cancer (LARC): A phase II study
    Torino, F.
    Cascinu, S.
    Ciardiello, F.
    Ballestrero, A.
    Lencioni, M.
    Filippelli, G.
    Martignetti, A.
    Granetto, C.
    Sarmiento, R.
    Gasparini, G.
    ANNALS OF ONCOLOGY, 2008, 19 : 57 - 57
  • [32] A phase I trial of Capecitabine plus Gemcitabine with radical radiation for locally advanced pancreatic cancer
    Michael, M.
    Price, T.
    Ngan, S. Y.
    Ganju, V.
    Strickland, A. H.
    Muller, A.
    Khamly, K.
    Milner, A. D.
    Dilulio, J.
    Matera, A.
    Zalcberg, J. R.
    Leong, T.
    BRITISH JOURNAL OF CANCER, 2009, 100 (01) : 37 - 43
  • [33] Adding oxaliplatin (OX) do neoadjuvant therapy of locally advanced rectal cancer (LARC): Still promising option?
    Rogowski, W.
    Wyrwicz, L.
    Sulzyc-Bielicka, V.
    ANNALS OF ONCOLOGY, 2018, 29
  • [34] Comparing Capecitabine Plus Oxaliplatin Versus Capecitabine Plus Oxaliplatin With Concurrent Capecitabine Radiation Therapy in Completely Resected Gastric Cancer
    Zhang, L. Y.
    Wu, Y. Y.
    Qian, J. J.
    Chen, L. S.
    Tian, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S316 - S316
  • [35] LATE COMPLICATIONS OF HYPERFRACTIONATED PREOPERATIVE RADIATION THERAPY (RT) IN LOCALLY ADVANCED RECTAL CANCER (LARC)?
    Bieri, S.
    Gervaz, P.
    Bonet, M.
    Franzetti-Pellanda, A.
    Roth, A.
    Allal, A. S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 (11) : 626 - 626
  • [36] Phase I study results of external beam radiation therapy (EBRT), oxaliplatin (OX), bevacizumab (BV), and capecitabine (CAP) for locally advanced, unresectable or metastatic adenocarcinoma of the rectum
    Czito, B.
    Willett, C.
    Hurwitz, H.
    Morse, M.
    Tyler, D.
    Ludwig, K.
    Mantyh, C.
    Vaccaro, G.
    Taylor, S.
    Bendell, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S263 - S263
  • [37] Preliminary results of a phase I study of external beam radiation therapy (EBRT), oxaliplatin (OX), bevacizumab (BV), and capecitabine (CAP) for locally advanced or metastatic adenocarcinoma of the rectum
    Bendell, J.
    Czito, B.
    Willett, C.
    Vaccaro, G.
    Morse, M.
    Yu, D.
    Honeycutt, W.
    Franklin, A.
    Hurwitz, H.
    ANNALS OF ONCOLOGY, 2006, 17 : 103 - 103
  • [38] Preliminary results of a phase I study of external beam radiation therapy (EBRT) oxaliplatin (OX), bevacizumab (BV), and capecitabine (CAP) for locally advanced or metastatic adenocarcinoma of the rectum
    Czito, B
    Bendell, J
    Willett, C
    Morse, M
    Tyler, D
    Fernando, N
    Mantyh, C
    Blobe, G
    Honeycutt, W
    Yu, D
    Ludwig, K
    Hurwitz, H
    RADIOTHERAPY AND ONCOLOGY, 2006, 78 : S54 - S54
  • [39] Feasibility study of combined preoperative intensity-modulated radiation therapy (PIMRT) with concurrent capecitabine/oxaliplatin in patients with locally advanced rectal cancer (LARC)
    Arbea Moreno, L.
    Aristu, J.
    Moreno, M.
    Garran, C.
    Nagore, G.
    Valero, J.
    Hernandez, J.
    Sola, J.
    Rodriguez, J.
    Martinez-Monge, R.
    EJC SUPPLEMENTS, 2005, 3 (02): : 183 - 183
  • [40] S0713: A phase II study of cetuximab (CET) added to induction chemotherapy (ICT) of oxaliplatin (OX) and capecitabine (CAP), followed by neoadjuvant chemoradiation (NACR) for locally advanced rectal cancer (LARC).
    Leichman, Cynthia G.
    McDonough, Shannon L.
    Smalley, Stephen R.
    Billingsley, Kevin G.
    Lenz, Heinz-Josef
    Beldner, Matthew A.
    Hezel, Aram F.
    Velasco, Mario R.
    Guthrie, Katherine A.
    Blanke, Charles David
    Hochster, Howard S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345